SOM SomnoMed Limited
—Mkt Cap: —P/E: —1d ago
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as S…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value29.87M USD
Revenue (TTM)79.15M USD
Gross Profit48.39M USD
Net Income (TTM)-1.83M USD
Revenue/Share0.53 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000SOM1
Valuation
P/E (Trailing)—
P/E (Forward)10.54
PEG0.99
EV/EBITDA14.35
EV/Revenue0.38
P/S0.48
P/B1.16
EPS (TTM)-0.01
EPS (Forward)0.02
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin61.13%
Oper. Margin-3.40%
EBITDA Margin2.63%
Profit Margin-2.31%
ROE-5.59%
ROA-3.53%
Growth
Revenue Growth-6.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.72M USD
CapEx (TTM)3.96M USD
FCF Margin2.67%
FCF Yield—
Net Debt-8.10M USD
Net Debt/EBITDA-3.89
Balance Sheet
Debt/Equity0.12
Current Ratio1.67
Quick Ratio1.24
Book Value/Sh0.22 AUD
Cash/Share0.08 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateNov 27, 2009
Analyst Consensus
Rating—
Target (Mean)0.8367 AUD
Target Range0.7600 AUD – 0.9900 AUD
# Analysts3
Ownership
Shares Out.219.77M
Float101.02M
Insiders26.01%
Institutions63.37%
Technical
SMA 500.3296 AUD
SMA 2000.5299 AUD
Beta0.83
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)49.18K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—